RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
كلام هايل!
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
Hot off the press from @bmj_latest Intra-operative radiotherapy during lumpectomy maybe as safe as post-operative whole breast radiotherapy. Potentially big implications for patients cancer treatment journey and also long term cosmetic outcomes https
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
Una única dosis de radioterapia en el quirófano es tan eficaz como un curso de 3-5 semanas para pacientes de cáncer de mama con ganglios negativos @bmj_latest https://t.co/Cq7dcMGWE3 https://t.co/70GNUdv8Zx
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
New evidence from @ucl challenges traditional treatments for early #BreastCancer. https://t.co/VjmEsYPwuE
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
Every patient with early breast cancer should be offered this form of radiotherapy. It’s scandalous to put women through weeks of unnecessary treatment when the one stop Interoperative Radiotherapy option is just as effective, cheaper and safer #IORT
RT @dr_xrt: Huge relevance if linac access limited (LMICs) or undesirable (pandemic): Long term survival and local control outcomes from s…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @mdAlvaradoMD: TARGIT IORT for early stage breast cancer. So excited about these excellent results!! https://t.co/3a9NnbWFsr
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @bmj_company: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as con…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_company: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as con…
For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conventional radiotherapy, suggest new findings published in @bmj_latest https://t.co/Gp90ckdUnO @jsvaidya
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
Whilst I recognise the topic in question, what is the value of including an image of a young woman’s bare breast as part of this tweet? #seriousquestion
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/stogvmDphq
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conventional radiotherapy, which requires several visits to hospital after surgery, according to #BMJResearch @jsvaidya https://t.co/1slt
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/iyY04b3bsQ
An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the operating room is as effective as a3 -5 week course for node negative breast Cancer https://t.co/09HD1LnRQC
Finally our long-term results are available....so happy to have them published. Check out here - open source 👇
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ. This is standard of care! https://t.co/43xGrvV1Kb
TARGIT-IORT for early breast cancer (who meet trial selection criteria) is an effective alternative to EBRT https://t.co/lWn4iVACOG https://t.co/WymroECYF8
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/UhbuzuqHfy https://t.co/gm3ddzYbrq
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/PbQTCkKHHo
#bmj Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/N7reKCOkQF
RT @dr_xrt: Huge relevance if linac access limited (LMICs) or undesirable (pandemic): Long term survival and local control outcomes from s…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/WmQd9dHv3Y https://t.co/Bf1uHnbT62
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/Cct246KPDq
For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effective as 3-6 weeks’ of daily post-operative whole breast radiotherapy in the TARGIT-A randomised trial #RCT. https://t.co/dn6N2OVFPb .
RT @dr_xrt: Huge relevance if linac access limited (LMICs) or undesirable (pandemic): Long term survival and local control outcomes from s…
Huge relevance if linac access limited (LMICs) or undesirable (pandemic): Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A clinical trial
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/UmrxKHaiZj https://t.co/wQPm9eAWXa
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/VV169lkNj7
TARGIT IORT for early stage breast cancer. So excited about these excellent results!! https://t.co/3a9NnbWFsr